1.

Henriksen JH, Bendtsen F, Hansen EF, Moller S. Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol 2004;40:239-46.

2. 3.

Henriksen JH, Moller S. Liver cirrhosis and arterial hypertension. World J Gastroenterol 2006;12:678-85. Camm AJ, Janse MJ, Roden DM, Rosen MR, Cinca J, Cobbe SM. Congenital and acquired long QT syndrome. Eur Heart J, 2000; 21:1232-7.

4. 5.

Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN. The QT interval. Progress Cardiovasc Dis, 2001;43:1-45. Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo ML, Sica G, et al. QT Interval prolongation in cirrhotic: prevalence, relationship with severity and etiology of the disease and possible pathogenetic factors. Hepatology, 1998;27:28-34

6.

Trevisani F, Sica G, Mainqua P, Caraceni P, Colantoni A, De Notariis S, et al. Normalization of prolonged QT interval after liver transplantation in cirrhotic. Hepatology, 1996;24:179A.

7.

Firmansyah I, Hasan I, Lesmana LA, Alwi I, Rahardjo P. Prolonged QTcInterval in Liver Cirrhotic Patient: Prevalence and Its Relationship with Severity of GM. Liver Long Dysfunction. QT 2004;5. Available Clin, at: www.inajghe.com/?page=journal.download_process&id=166

8.

Vincent

syndrome.

Cardiol

2000;18:1-20.

http://home.mdconsult.com/das/article/body/l/jorg=journal&source=MI &sp=1133499&sid=113243562./l.htm.

9.

Mohamed R, Forsey PR, Davies MK, Neuberger JM. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology, 1996;23:1128-34.

10. Malik M, Batchvarov V. QT-dispersion. In: Camm AJ, Ed. Clinical approaches to tachyarrhythmias. New York: Futura Publishing Company, Inc, 2000; p.29-54. 11. Lee RF, Glenn TK, Lee SS. Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:125-40. 12. Wong F. Cirrhotic cardiomyopathy. Hepatol Int. 2009;3:294-304. 13. Zambruni A, Di Micoli A, Lubisco A, Domenicali M, Trevisani F, Bernardi M. QT interval correction in patients with cirrhosis. J Cardiovasc Electrophysiol. 2007;18:77-82. 14. Kosar F, Ates F, Sahin I, Karincaoglu M, Yildirim B. QT interval analysis in patients with chronic liver disease: a prospective study. Angiology. 2007;58:218-24. 15. Zuberi BF, Ahmed S, Faisal N, Afsar S, Memon AR, Baloch I et al. Comparison of heart rate and QTc duration in patients of cirrhosis of liver with non-cirrhotic controls. J Coll Physicians Surg Pak. 2007;17:6971. 16. Li L, Liu HR, Shu JL, Xi XP, Wang Y. Clinical investigation of Q-T prolongation in hepatic cirrhosis. Zhonghua Yi Xue Za Zhi. 2007;87:2717-8. 17. Zambruni A, Trevisani F, Di Micoli A, Savelli F, Berzigotti A, Bracci E, et al. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol. 2008;48:415-21. 18. Straus SM, Kors JA, De Bruin ML. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362-7.